USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Chr. Hansen HMO Gmbh

USPTO PatentsView assignee record - 17 granted patents across 15 technology areas, recorded in grant years 2022–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

13.9

Avg claims per patent

5-year grant velocity

The verdict

According to USPTO PatentsView, Chr. ranks #16,684 of 50,000 tracked US assignees by granted-patent volume, with 17 patents across 15 technology areas.

#16,684
of 50,000 US assignees by volume: Top 11%
by Innovation Score (52.0/100): 13.9
avg claims per patent

Portfolio overview

Chr. Hansen HMO Gmbh has been granted 17 US utility patents between 2022 and 2024, placing Chr. Hansen HMO Gmbh at #16,684 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.9 claims per patent with primary concentration in C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE). As a Foreign Corporation, Chr. Hansen HMO Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Chr. sits between Chengdu Vistar Optoelectronics Co., Ltd. (17 patents, rank #16,694) and Cloudparc, Inc. (17 patents, rank #16,702) - the closest US assignees by grant volume. The composite Innovation Score of 52.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Historical data spans 2022 through 2024, with 17 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Chr. Hansen HMO Gmbh's 13.9 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 15 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Chengdu Vistar Op…

17
Chi Hua Fitness

17
China Pacificarbi…

17
Choice Spine

17
Chromadex

17
Ciambella

17
Clayton

17
Cloudparc

17
Chr Hansen HMO ◀

17

What this shows Chr. holds 17 patents at rank #16,698, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Chr

By rank, the assignees closest to #16,698 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Chr's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Chr, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (52 here).

Latham Pool Products, Inc. 52 Advantest Test Solutions, Inc. 52 Unifrax I Llc 52 THE University OF Ottawa 52

Chr.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Chr. Hansen HMO Gmbh patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	2	11.8%
2023	7	41.2%
2024	8	47.1%

Which technologies does Chr. Hansen HMO Gmbh patent most?

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 15

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 12

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 11

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 11

C12Y - ENZYMES 7

A23V - INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION 6

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 5

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 4

C12R - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS 3

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2

C07K - PEPTIDES 2

A23B - PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES 1

A23P - SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS 1

A23C - DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF 1

B01D - SEPARATION 1

Top 15 of 15 technology areas

Grant record at a glance

Portfolio Volume 17 grants

CPC subclasses 15

Avg. claims / grant 13.9

Historical grant data only; it does not rate legal strength or current strategy.

Where it ranks

Overall rank by patents

#16,684

of 50,000 tracked assignees

Innovation Score

52.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

Where does Chr. Hansen HMO Gmbh rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Chr. Hansen HMO Gmbh ranks #16,684 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Chr. Hansen HMO Gmbh hold?

Chr. Hansen HMO Gmbh holds 17 US utility patents granted between 2022 and 2024, spanning 15 technology areas.

What is Chr. Hansen HMO Gmbh's Innovation Score?

Chr. Hansen HMO Gmbh has an Innovation Score of 52.0 out of 100 (top 11% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Chr. Hansen HMO Gmbh focus on?

Chr. Hansen HMO Gmbh's top technology area is C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE) with 15 patents. Grants appear in 15 CPC subclasses total.

Is Chr. Hansen HMO Gmbh's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Chr. Hansen HMO Gmbh.

What does claim depth mean for Chr. Hansen HMO Gmbh's patents?

Chr. Hansen HMO Gmbh's patents average 13.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Chr. Hansen HMO Gmbh patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Chr.'s 17 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Chr. ranks #16,684 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12P - see who else leads that technology area. C12P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.